Using β-lactam/β-lactamase inhibitors for infections due to extended-spectrum -lactamase-producing Enterobacteriaceae to slow the emergence of carbapenem-resistant Enterobacteriaceae

被引：4
作者：
Watkins, Richard R. [1 ,2 ]
Deresinski, Stan [3 ]
机构：
[1] Northeast Ohio Med Univ, Dept Internal Med, Rootstown, OH USA
[2] Cleveland Clin Akron Gen, Div Infect Dis, Akron, OH 44302 USA
[3] Stanford Univ, Dept Med, Div Infect Dis & Geog Med, Stanford, CA 94305 USA
来源：
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY | 2017年 / 15卷 / 10期
关键词：
Antimicrobial resistance; ESBL; beta-lactam/beta-lactamase inhibitors; CRE; blood stream infections; BLOOD-STREAM INFECTIONS; PIPERACILLIN-TAZOBACTAM; KLEBSIELLA-PNEUMONIAE; ESCHERICHIA-COLI; RISK-FACTORS; BACTEREMIA; PHARMACOKINETICS; MORTALITY; THERAPY; SPREAD;
D O I：
10.1080/14787210.2017.1380519
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：893 / 895
页数：3
相关论文
共 23 条
  • [1] Pharmacokinetics-pharmacodynamics of cefepime and piperacillin-tazobactam against Escherichia coli and Klebsiella pneumoniae strains producing extended-spectrum β-lactamases:: Report from the ARREST program
    Ambrose, PG
    Bhavnani, SM
    Jones, RN
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (05) : 1643 - 1646
  • [2] An update on the management of urinary tract infections in the era of antimicrobial resistance
    Bader, Mazen S.
    Loeb, Mark
    Brooks, Annie A.
    [J]. POSTGRADUATE MEDICINE, 2017, 129 (02) : 242 - 258
  • [3] Pharmacokinetics and Penetration of Ceftazidime and Avibactam into Epithelial Lining Fluid in Thigh- and Lung-Infected Mice
    Berkhout, Johanna
    Melchers, Maria J.
    van Mil, Anita C.
    Seyedmousavi, Seyedmojtaba
    Lagarde, Claudia M.
    Nichols, Wright W.
    Mouton, Johan W.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (04) : 2299 - 2304
  • [4] Efficacy of β-Lactam/β-Lactamase Inhibitor Combinations for the Treatment of Bloodstream Infection Due to Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae in Hematological Patients with Neutropenia
    Gudiol, Carlota
    Royo-Cebrecos, Cristina
    Abdala, Edson
    Akova, Murat
    Alvarez, Rocio
    Maestro-de la Calle, Guillermo
    Cano, Angela
    Cervera, Carlos
    Clemente, Wanessa T.
    Martin-Davila, Pilar
    Freifeld, Alison
    Gomez, Lucia
    Gottlieb, Thomas
    Gurgui, Merce
    Herrera, Fabian
    Manzur, Adriana
    Maschmeyer, Georg
    Meije, Yolanda
    Montejo, Miguel
    Peghin, Maddalena
    Rodriguez-Bano, Jesus
    Ruiz-Camps, Isabel
    Sukiennik, Teresa C.
    Tebe, Cristian
    Carratala, Jordi
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (08)
  • [5] A Multinational, Preregistered Cohort Study of β-Lactam/β-Lactamase Inhibitor Combinations for Treatment of Bloodstream Infections Due to Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae
    Gutierrez-Gutierrez, Belen
    Perez-Galera, Salvador
    Salamanca, Elena
    de Cueto, Marina
    Calbo, Esther
    Almirante, Benito
    Viale, Pierluigi
    Oliver, Antonio
    Pintado, Vicente
    Gasch, Oriol
    Martinez-Martinez, Luis
    Pitout, Johann
    Akova, Murat
    Pena, Carmen
    Molina, Jose
    Hernandez, Alicia
    Venditti, Mario
    Prim, Nuria
    Origuen, Julia
    Bou, German
    Tacconelli, Evelina
    Tumbarello, Mario
    Hamprecht, Axel
    Giamarellou, Helen
    Almela, Manel
    Perez, Federico
    Schwaber, Mitchell J.
    Bermejo, Joaquin
    Lowman, Warren
    Hsueh, Po-Ren
    Mora-Rillo, Marta
    Natera, Clara
    Souli, Maria
    Bonomo, Robert A.
    Carmeli, Yehuda
    Paterson, David L.
    Pascual, Alvaro
    Rodriguez-Bano, Jesus
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (07) : 4159 - 4169
  • [6] Meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections due to ceftriaxone non-susceptible Escherichia coli and Klebsiella spp (the MERINO trial): study protocol for a randomised controlled trial
    Harris, Patrick N. A.
    Peleg, Anton Y.
    Iredell, Jon
    Ingram, Paul R.
    Miyakis, Spiros
    Stewardson, Andrew J.
    Rogers, Benjamin A.
    McBryde, Emma S.
    Roberts, Jason A.
    Lipman, Jeff
    Athan, Eugene
    Paul, Sanjoy K.
    Baker, Peter
    Harris-Brown, Tiffany
    Paterson, David L.
    [J]. Trials, 2015, 16
  • [7] Bloodstream infections due to extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae:: Risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy
    Kang, CI
    Kim, SH
    Park, WB
    Lee, KD
    Kim, HB
    Kim, EC
    Oh, MD
    Choe, KW
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (12) : 4574 - 4581
  • [8] Liu P, 2017, MICROB DRUG RESIST
  • [9] Comparative assessment of inoculum effects on the antimicrobial activity of amoxycillin-clavulanate and piperacillin-tazobactam with extended-spectrum β-lactamase-producing and extended-spectrum β-lactamase-non-producing Escherichia coli isolates
    Lopez-Cerero, L.
    Picon, E.
    Morillo, C.
    Hernandez, J. R.
    Docobo, F.
    Pachon, J.
    Rodriguez-Bano, J.
    Pascual, A.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2010, 16 (02) : 132 - 136
  • [10] Madueno A, 2017, EPIDEMIOL INFECT, P1
123